# Task C18: APP Drug Candidate Manufacture Services

> **NIH NIH N01** · ALBANY MOLECULAR RESEARCH, INC. · 2022 · $218,000

## Abstract

: The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 10683812
- **Project number:** 272201800008I-0-759302200002-1
- **Recipient organization:** ALBANY MOLECULAR RESEARCH, INC.
- **Principal Investigator:** MELISSA ALLARD
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $218,000
- **Award type:** —
- **Project period:** 2022-05-01 → 2022-11-01

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10683812

## Citation

> US National Institutes of Health, RePORTER application 10683812, Task C18: APP Drug Candidate Manufacture Services (272201800008I-0-759302200002-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10683812. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*